Results 31 to 40 of about 1,458,916 (304)
Travel and Oral Anticoagulation [PDF]
Journal of Travel Medicine, 2009 Millions of individuals worldwide are on permanent or temporary oral anticoagulation treatment with vitamin K antagonists (VKAs). The effectiveness of VKAs has been established by clinical trials for several indications. Among these, the primary or secondary prevention of venous thromboembolism, the prevention of systemic embolism in patients with ...
Jürgen, Ringwald +2 more
openaire +2 more sources
Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases [PDF]
, 2013 We present the case of an aphasic 77-year-old stroke patient with left distal M1 occlusion who received rt-PA for thrombolysis while on oral anticoagulant treatment with dabigatran (150 mg b.i.d.).
Baas, Horst +7 more
core +1 more source
, 2022 Gastrointestinal bleeding (GIB) associated with the use of direct oral anticoagulants or, as they are also called, new oral anticoagulants (NOAC) is a serious medical problem, the relevance of which will only increase taking into account the constant ...
Natalya M. Vorobyeva +3 more
core +1 more source
Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
Рациональная фармакотерапия в кардиологии, 2021 Atrial fibrillation and renal dysfunction often coexist, each disorder may predispose to the other and contribute to worsening prognosis. Both atrial fibrillation and chronic kidney disease are associated with increased risk of stroke and thromboembolic ...
Z. D. Kobalava +2 more
doaj +1 more source
Consequences of oral antithrombotic use in patients with chronic kidney disease
Clinical and Translational Science, 2021 We assessed the risks of bleeding, acute kidney injury (AKI), and kidney failure associated with the prescription of antithrombotic agents (oral anticoagulants and/or antiplatelet agents) in patients with moderate‐to‐advanced chronic kidney disease (CKD).
Solène M. Laville +14 more
doaj +1 more source
Reversal of Oral Anticoagulation [PDF]
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Although the use of dabigatran and rivaroxaban are increasing, data on the reversal of their effects are limited. The lack of reliable monitoring methods and specific reversal agents renders treatment strategies empirical, and as a result, treatment consists mainly of supportive measures.
Jonathan L, Thigpen, Nita A, Limdi
openaire +2 more sources
Global access to affordable direct oral anticoagulants [PDF]
, 2021 Poor control of cardiovascular disease accounts for a substantial proportion of the disease burden in developing countries, but often essential anticoagulant medicines for preventing strokes and embolisms are not widely available.
Magrini, Nicola +12 more
core +1 more source
Use of New Oral Anticoagulants/ Direct Oral Anticoagulants in Malignant Patients [PDF]
Cureus, 2020 Vitamin K antagonists are being used in the last five decades as an effective anticoagulant. However, for the past few years, new oral anticoagulants (NOACs) have been introduced as newer anticoagulant agents, which are gradually replacing the previously used vitamin K antagonist.
Khan, Yusra +4 more
openaire +2 more sources
Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022 A post-COVID patient with a high D-dimer Value (>5000 IU) was posted for total knee replacement. She was on multiple anticoagulants including the novel oral anticoagulants that started to reduce thrombotic risk.
Balasubramaniam Gayathri +3 more
doaj +1 more source
Non-Vitamin K Oral Anticoagulants (NOACs)
, 2023 Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) have revolutionized the field of anticoagulation therapy, offering a significant advancement over conventional anticoagulants like warfarin.
Elias, Ala
core